-
RGX-202 gene therapy meets main goal in Phase 3 DMD clinical trial
The Phase 3 portion of a clinical trial testing RGX-202, an investigational gene therapy for
-
When it comes to raising a child with DMD, the third time is not the charm
They say the third time is the charm. However, as a mom to three sons








